trimetazidine / Generic mfg. |
ChiCTR-TRC-13003298: Oral Trimetazidine for Reducing the Symptoms of Acute Mountain Sickness and Improving Exercise Performance |
|
|
| Completed | 4 | 40 | | Oral Trimetazidine 20mg, Tid ;Oral placebo 20mg, Tid | Institute of Cardiovascular Diseases of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing, China; Level of the institution:, Supported by the Special Health Research Project, the Ministry of Health of the People's Republic of China (201002012) | acute mountain sickness | | | | |
| Recruiting | 4 | 180 | | Based on the control group treatment programme and treated with full use of Aspartate ornithine, oral with trimetazidine 20mg / piece, 20mg/ times, 3 times / day, three meals a day, for 4 weeks. ;conventional treatment ;Based on the control group treatment, L-ornithine-L-aspartate (LOLA) 10 mg IV daily | The First Affiliated Hospital of Zhengzhou University; The First Affiliated Hospital of Zhengzhou University, National Science technology research program | liver failure | | | | |
| Completed | 4 | 56 | | After meals: the test formulation was given in the first phase, and reference formulation was given in the second phase; After meals: the reference formulation was given in the first phase, and test formulation was given in the second phase; Fasting: the test formulation was given in the first phase, and reference formulation was given in the second phase; Fasting: the reference formulation was given in the first phase, and test formulation was given in the second phase | Guangzhou Panyu Central Hospital; Guangzhou Panyu Central Hospital, Sponsor's funding | Cardiovascular disease | | | | |
ChiCTR1800017008: Effect of trimetazidine on autonomic nervous function in patients undergoing percutaneous coronary intervention |
|
|
| Not yet recruiting | 4 | 400 | | Routine protocol + Trimetazidine ;Routine protocol, include Low-molecular heparin, aspirin, clopidogrel, statin, ACEI or ARB, purge - receptor blockers and nitrates, depends on status of the disease | the Second Hosptial of Hebei Medical University; the Second Hosptial of Hebei Medical University, Self - financing | Coronary Heart Disease | | | | |
2020-001617-21: The Effect of Trimetazidine on Cardiac Function in Patients with Cardiac Amyloidosis. Effekten af Trimetazidin på Hjertefunktion ved Patienter med Hjerteamyloidose. |
|
|
| Not yet recruiting | 4 | 36 | Europe | Vastarel | Aarhus University Hospital, Department of Cardiology, Aarhus University Hospital | Wild-Type Transthyretin Cardiac Amyloidosis, Cardiac Amyloidosis Hjerteamyloidose, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
CADLVH, ChiCTR1800017876: the effect of trimetazidine on myocardial ischemia, remodeling and long-term prognosis in CAD patients with hypertensive hypertrophy after PCI |
|
|
| Recruiting | 4 | 124 | | trimetazidine ;placebo | Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University; Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China Cardiovascular Association-Cardiac Rehabilitation and metabolic therapy research fund | coronary artery disease | | | | |
HEARTRIP, NCT03809273: Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI |
|
|
| Recruiting | 4 | 668 | RoW | Yangxinshi, Trimetazidine, Yangxinshi mimic, Trimetazidine mimic | Shenyang Northern Hospital | Percutaneous Coronary Intervention | 12/20 | 12/20 | | |
2021-001564-26: Evaluation of the cardioprotective metabolic effect of trimetazidine in patients with myocardial ischaemia Valutazione dell’effetto metabolico cardioprotettivo della Trimetazidina in pazienti con ischemia miocardica |
|
|
| Not yet recruiting | 4 | 10 | Europe | Trimetazidina, [Trimetazidina], Tablet, VASTAREL - 20 MG COMPRESSE RIVESTITE 60 COMPRESSE | FONDAZIONE TOSCANA GABRIELE MONASTERIO, Fondazione Toscana Gabriele Monasterio | Patients with clinical diagnosis of Inducible Myocardial Ischemia (exercise stress test positive for electrocardiographic criteria and /or symptoms) Pazienti con diagnosi clinica di cardiopatia ischemica (test da sforzo positivo per criteri elettrocardiografici e/osintomi), Patients with Inducible Myocardial Ischemia Pazienti con cardiopatia ischemica, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
NCT04661709: Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris |
|
|
| Not yet recruiting | 4 | 502 | NA | Wen Xin granule, WXG, Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet, Atorvastatin Calcium, Isosorbide Mononitrate Tab 20 MG, Metoprolol Tartrate Tab 25 MG, Aspirin Enteric-coated Tablets, WXG placebo, Trimetazidine Dihydrochloride Tablets, glyceryl trinitrate | Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Special Project of National Traditional Chinese Medicine Clinical Research Base of State Administration of Traditional Chinese Medicine, National Natural Science Foundation of China | Coronary Heart Disease, Unstable Angina, Chinese Herbal Medicine | 03/23 | 06/23 | | |
CACTuS - TMZ, NCT05633563: The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis |
|
|
| Completed | 4 | 24 | Europe | Trimetazidine, Placebo | Steen Hvitfeldt Poulsen | Transthyretin Amyloid Cardiopathy, Mitochondrial Pathology | 06/23 | 06/23 | | |
ChiCTR2300074471: To explore whether trimetazidine can improve cardiac function in adult cyanotic congenital heart disease patients with hypoxia |
|
|
| Not yet recruiting | 4 | 80 | | placebo; Trimetazidine hydrochloride tablets | Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine; Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, National Natural Science Foundation of China (No. : U20A2018) | Cyanotic congenital heart disease | | | | |
NCT05540184: Allopurinol and Trimetazidine as a Preventive of Acute Kidney Injury in PCI Patients |
|
|
| Recruiting | 4 | 124 | RoW | Trimetazidine 35 mg, Vastarel MR, Allopurinol 300 MG, Zyloric 300mg, Normal saline, 0.9 NS | Beni-Suef University, Cairo University | AKI - Acute Kidney Injury | 09/25 | 09/25 | | |
ChiCTR2300074976: A single-arm clinical trial to evaluate the efficacy and safety of Simvastatin, Orlistat, and Trimetazidine in combination with second-line treatment drugs for advanced liver cancer |
|
|
| Recruiting | 4 | 43 | | Patients with advanced liver cancer received Simvastatin 20mg po qn, Orlistat 120mg po tid, Trimetazidine 20mg po tid combined with second-line treatment drugs for advanced liver cancer | Affiliated Hospital of Qingdao University; Affiliated Hospital of Qingdao University, Self-funding for scientific research | Liver cancer | | | | |
2007-002893-76: MEtabolic Therapy with Trimetazidine in Acute heart failure: an open pilot randomized trial (The METTA – PRAGUE 10 Trial) |
|
|
| Ongoing | 3 | 100 | Europe | Preductal MR, Preductal MR | Charles University in Prague, Third Faculty of Medicine | Acute Heart Failure | | | | |
2010-022134-89: Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries. |
|
|
| | 3 | 820 | Europe, RoW | S06790, S06790, VASTAREL MR 35mg, VASTAREL MR 35mg | I.R.I.S., ADIR | Patients with Angina pectoris having been treated by Percutaneous Coronary Intervention | | | | |
NCT06656442: "The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients" |
|
|
| Recruiting | 3 | 60 | RoW | Trimetazidine, Vastarel Mr, Metacardia Mr | Ain Shams University | Acute Ischemic Stroke | 12/25 | 12/25 | | |
NCT04939857: Effect of Trimetazidine on Radiotherapy-induced Heart Damage. |
|
|
| Not yet recruiting | 2/3 | 80 | NA | Trimetazidine | Peking University Third Hospital | Cardiotoxicity | 07/22 | 08/22 | | |
ACTRN12622000474752p: TIDE (Trimetazidine in bipolar depression): A double-blind, randomised, placebo-controlled trial |
|
|
| Not yet recruiting | 2 | 180 | | | Deakin University, Stanley Medical Research Institute | Bipolar depression | | | | |
ACTRN12622000474752: TIDE (Trimetazidine in bipolar depression): A double-blind, randomised, placebo-controlled trial |
|
|
| Not yet recruiting | 2 | 260 | | | Deakin University, Stanley Medical Research Institute | Bipolar depression | | | | |
2016-002270-12: Clinical study to evaluate the preventive effect of trimetazidine on cardiac toxicity from chemotherapy in patients with breast cancer Studio clinico per valutare l'effetto preventivo della trimetazidina sulla tossicit¿ cardiaca da chemioterapia in pazienti con tumore della mammella |
|
|
| Not yet recruiting | 2 | 242 | Europe | VASTAREL, Film-coated tablet, VASTAREL - 20 MG COMPRESSE RIVESTITE 60 COMPRESSE | AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, AZIENDA OSPEDALIERO UNIVERSITARIA PISANA | BREAST CANCER CARCINOMA DELLA MAMMELLA, BREAST CANCER TUMORE DELLA MAMMELLA, Diseases [C] - Cancer [C04] | | | | |
PREMIER, NCT04760821: Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19 |
|
|
| Recruiting | 2 | 80 | RoW | Trimetazidine | Ministry of Health, Brazil, InCor Heart Institute | Acute Respiratory Distress Syndrome, Covid19, Myocardial Injury | 04/21 | 04/21 | | |
2020-005018-17: Safety and tolerability of Trimetazidine in amyotrophic lateral sclerosis (ALS) Het bestuderen van de veiligheid en verdraagzaamheid van Trimetazidine bij patiënten met amyotrofische laterale sclerose (ALS) |
|
|
| Ongoing | 2 | 36 | Europe | Trimetazidine, 201600930, Tablet, Vastarel | The University of Queensland, FightMND | Patients suffering from amyotrophic lateral sclerosis (ALS) Patiënten met de ziekte amyotrofische laterale sclerose (ALS), Patients with ALS, also known as a motor neuron disease (MND) or as Lou Gehrig's Disease Patiënten met ALS, Diseases [C] - Nervous System Diseases [C10] | | | | |
2018-002170-52: TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction Trimetazidine voor diastolisch hartfalen |
|
|
| Not yet recruiting | 2 | 25 | Europe | Vastarel, Film-coated tablet, Vastarel | VU University Medical Center (VUmc), Amsterdam Cardiovascular Sciences, VUmc/Department of Cardiology | Heart failure with preserved ejection fraction (HFpEF), Diastolic heart failure Diastolisch hartfalen, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Completed | 2 | 21 | Europe, RoW | Trimetazidine Dihydrochloride | The University of Queensland, FightMND, UMC Utrecht, King's College London, Julius Clinical | Amyotrophic Lateral Sclerosis, Motor Neuron Disease | 05/23 | 05/23 | | |
| Recruiting | 2 | 60 | RoW | Trimetazidine Dihydrochloride, Vasteral mr, Placebo | Ain Shams University | Diabetes Mellitus, Type 2, Diabetic Cardiomyopathies | 09/23 | 09/23 | | |
| Recruiting | 2 | 60 | RoW | conventional treatment, conventional treatment ( anti diabetic drugs and antihyperlipidimic drugs ), Furosemide or other alternatives , Niaspan or other alternatives, conventional therapy, Trimetazidine, furosemide or other alternative , niaspan or other alternative | October 6 University | Non-Alcoholic Fatty Liver Disease | 06/24 | 09/25 | | |
| Not yet recruiting | 2 | 150 | NA | Trimetazidine | Tongji Hospital | Diabetic Nephropathies | 12/23 | 12/23 | | |
ACTRN12620000945921: Safety and tolerability of Trimetazidine in amyotrophic lateral sclerosis (ALS) |
|
|
| Not yet recruiting | 1/2 | 36 | | | The University of Queensland, FightMND | Amyotrophic Lateral Sclerosis | | | | |
| Not yet recruiting | 1/2 | 36 | | | The University of Queensland, FightMND | Amyotrophic Lateral Sclerosis | | | | |
NCT06459193: Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy |
|
|
| Recruiting | 1/2 | 60 | RoW | Trimetazidine, Placebo | Minia University | Peripheral Neuropathy Due to Chemotherapy | 11/24 | 11/24 | | |
| Not yet recruiting | 1 | 52 | | investigational product | Xiyuan Hospital, CACMS; Baimeite Biopharmaceutical Co Ltd, sponsor's funding | Not Applicable | | | | |
ChiCTR1800016293: Shenmai injection and the main components of ginseng total saponinsThe mechanism of influence on metabolic group of heart failure |
|
|
| Recruiting | 1 | 100 | | blank ;Use of Shenmai vein ;Oral use of Trimetazidine ;Levocarnitine intravenous use | Zhejiang Province People's Hospital; Zhejiang Province People's Hospital, self | Heart failure | | | | |
ChiCTR2000035293: Bioequivalence of Trimetazidine Dihydrochloride Modified Release Tablets (Fasting /Feeding) in the Healthy Human Body: a Randomized Cross-Over Controlled Trial |
|
|
| Recruiting | 1 | 48 | | phase I: T; phase II: R ;phase I: R; phase II: T ;phase I: T; phase II: R ;phase I: R; phase II: T | Xiangya Boai Rehabilitation Hospital; Synco (K.K.) Limited, Synco (K.K.) Limited | Pharmacokinetics and Bioequivalence Study in human | | | | |
ChiCTR2300077163: A multicenter randomized controlled study of the effects of wide-chest aerosol on anxiety and depression in patients with coronary heart disease after PCI |
|
|
| Not yet recruiting | 1 | 330 | | All patients received routine treatment from the hospital's medical staff. These include predictive drugs (aspirin, beta-blockers, statins, ACEI), symptom-improving drugs (nitrates, calcium antagonists), and other metabolic drugs (trimetazidine). Try to keep the type and dosage of medication the same. In this group, on top of the basic treatment, the use of broad chest aerosol was increased, and the broad chest aerosol was sprayed sublingual, 3 sprays/time, 3 times/day, for 48 weeks.; All patients received routine treatment from the hospital's medical staff. These include predictive drugs (aspirin, beta-blockers, statins, ACEI), symptom-improving drugs (nitrates, calcium antagonists), and other metabolic drugs (trimetazidine). Try to keep the type and dosage of medication the same. In this group, on top of the basic treatment, the use of a placebo was increased, and the use method, dosage, and duration of the placebo were the same as that of wide-chest aerosol. | Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Hangzhou Municipal Health Commission -- Hangzhou Bio-medicine and health Industry development support science and technology project | Anxiety and depression after PCI of coronary heart disease | | | | |
ChiCTR1900025018: A Randomized, Double-Blind, Placebo-Controlled Trial for the Myocardial Protection of Trimetazidine in Elderly Coronary Artery Disease Patients Undergoing Non-cardiac Surgery |
|
|
| Completed | N/A | 60 | | trimetazidine ;Nil | Shenzhen People's Hospital; None, Shenzhen Science and Technology Research Fund | coronary artery patients | | | | |
ChiCTR-INR-17010449: Preventive effect of coenzyme Q10 and trimetazidine on contrast-induced nephropathy in patients with renal insufficiency undergoing percutaneous coronary intervention |
|
|
| Recruiting | N/A | 146 | | coenzyme Q10 and trimetazidine ;placebo | The second Hospital of Hebei Medical University; he second Hospital of Hebei Medical University No, Project of science and Technology Department of Hebei Province | contrast-induced nephropathy | | | | |
ChiCTR1800015000: Trimetazidine modified release tablets in Angina and Poor muscle function (TAP): a randomized controlled study |
|
|
| Recruiting | N/A | 60 | | A dose of 35mg oral TMZ is administered during 2 times of meal a day besides conventional treatments in TMZ group for 3 months. ;Routine treatment | Chinese PLA General Hospital; Chinese PLA General Hospital, China Foundation for the Promotion of Health | stable angina | | | | |
ChiCTR1900021275: Protective effect of trimetazidine and nicorandil on renal function in patients undergoing elective percutaneous coronary intervention |
|
|
| Not yet recruiting | N/A | 400 | | standardized hydration treatment ;Trimetazidine+standardized hydration treatment ;Nicorandil+standardized hydration treatment ;Trimetazidine+nicorandil+standardized hydration treatment | Qilu Hospital of Shandong University; Qilu Hospital of Shandong University, the National Natural Science Foundation of China | Contrast-induced nephropathy | | | | |
NCT04702906: Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity |
|
|
| Not yet recruiting | N/A | 40 | NA | standard treatment, trimetazidine hydrochloride "metacardia" ® 20 mg tablet | Tanta University | Aluminum Phosphide Poisoning | 06/21 | 07/21 | | |
ChiCTR1900021608: A Randomized Controlled Trial for the Effect of Yiqi Huoxue Decoction on Exercise Tolerance in Patients with Chronic Stable Coronary Heart Disease |
|
|
| Not yet recruiting | N/A | 108 | | Yiqi Huoxue decoction; ;Trimetazidine | Dongfang Hospital; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Municipal Finance for Science and Technology; Hospital Self-financing | Chronic Stable Coronary Disease | | | | |
ChiCTR2000038559: Feasibility and application of trimetazidine in 18F-FDG PET myocardial metabolic imaging of diabetic mellitus patients |
|
|
| Completed | N/A | | | | The Third Affiliated Hospital of Suzhou University / Changzhou First People's Hospital; The Third Affiliated Hospital of Suzhou University / Changzhou First People's Hospital, Science and Technology Plan of Jiangsu Province-Standardization of Diagnosis and Treatment of Key Diseases Project | diabetic mellitus, coronary artery disease | | | | |
V-GOOD, NCT06464276: Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The Study |
|
|
| Completed | N/A | 800 | RoW | No intervention | Ministry of Health, Brazil, Servier | Chronic Coronary Syndrome, Stable Angina | 06/22 | 09/22 | | |
NCT06298045: Effectiveness of a Combination of Trimetazidine With One Hemodynamic Agent in Patients Recently Diagnosed With Stable Angina and Still Symptomatic Despite First Line Hemodynamic Therapy |
|
|
| Recruiting | N/A | 600 | Europe | | Servier Affaires Médicales | Stable Angina | 03/25 | 03/25 | | |
METHOD, NCT05210465: Objective Confirmation of thе Anti-ischemic Effectiveness of Trimetazidine 80mg Once Daily in Patients With Stable Angina Who Had a History of Myocardial Infarction |
|
|
| Completed | N/A | 36 | RoW | speckle tracking mode of the stress ECHO test with dobutamine | Servier Russia | Coronary Artery Disease | 11/23 | 04/24 | | |